Browsing Centre for Clinical Pharmacology by Subject "[18F]CETO"

Now showing items 1-1 of 1

    • First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours. 

      Silins, I; Sundin, A; Lubberink, M; O'Sullivan, L; Gurnell, M; Aigbirhio, F; Brown, M; Wall, A; Åkerström, T; Roslin, S (2023-01)
      PURPOSE: [11C]Metomidate positron emission tomography (PET) is currently used for staging of adrenocortical carcinoma and for lateralization in primary aldosteronism (PA). Due to the short half-life of carbon-11 and a high ...